Diabetes-related molecular signatures in infrared spectra of human saliva

Diabetology and Metabolic Syndrome

Volumn 2, Issue 1, 2010, Pages

  Scott, David A ^a,b   Renaud, Diane E ^a   Krishnasamy, Sathya ^b   Meriç, Pinar ^c   Buduneli, Nurcan ^c   Çetinkalp, Şvetki ^c   Liu, Kan Zhi ^d,e  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c EGE UNIVERSITY   (Turkey)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID; GLUCOSE; LIPID; PROTEIN; THIOCYANATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INFRARED SPECTROSCOPY; MALE; PRIORITY JOURNAL; SALIVA;

EID: 77955409447     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-2-48     Document Type: Article

References (41)

1. Diagnosis and classification of diabetes mellitus. A.D.A., Diabetes Care 2007 30 Suppl 1 42 47 17192378
2. Standards of medical care in diabetes. Diabetes Care 2007 30 Suppl 1 4 S41 17192377
3. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. R Paroni F Ceriotti R Galanello G Battista Leoni A Panico E Scurati R Paleari L Chemello V Quaino L Scaldaferri, et al. Clin Biochem 2007 40 18 1398 1405 10.1016/j.clinbiochem. 2007.08.001 17919531
4. Dynamic tests in the clinical management of diabetes. A Picardi P Pozzilli, J Endocrinol Invest 2003 26 7 Suppl 99 106 14604072
5. Recent advances in the monitoring and management of diabetic ketoacidosis. TM Wallace DR Matthews, Qjm 2004 97 12 773 780 10.1093/qjmed/hch132 15569808
6. Enhancing the predictive value of urinary albumin for diabetic nephropathy. ML Caramori P Fioretto M Mauer, J Am Soc Nephrol 2006 17 2 339 352 10.1681/ASN.2005101075 16394108
7. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. RJ Macisaac C Tsalamandris MC Thomas E Premaratne S Panagiotopoulos TJ Smith A Poon MA Jenkins SI Ratnaike DA Power, et al. Diabet Med 2007 24 4 443 448 10.1111/j.1464-5491. 2007.02112.x 17388960
8. Autoantibody markers for the diagnosis and prediction of type 1 diabetes. CH Wasserfall MA Atkinson, Autoimmun Rev 2006 5 6 424 428 10.1016/j.autrev. 2005.12.002 16890898
9. Autoimmune diagnostics in diabetes mellitus. J Seissler WA Scherbaum, Clin Chem Lab Med 2006 44 2 133 137 10.1515/CCLM.2006.025 16475896
10. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. NE Cameron MA Cotter, Curr Drug Targets 2008 9 1 60 67 10.2174/138945008783431718 18220713
11. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure. D Aronson, Med Hypotheses 2002 59 3 297 301 10.1016/S0306-9877(02)00172-X 12208156
12. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. M Brownlee A Cerami H Vlassara, N Engl J Med 1988 318 20 1315 1321 3283558
13. A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics. S Aydin, J Biochem Mol Biol 2007 40 1 29 35 17244479
14. Salivary alterations in insulin-dependent diabetes mellitus. MA Belazi A Galli-Tsinopoulou D Drakoulakos A Fleva PH Papanayiotou, Int J Paediatr Dent 1998 8 1 29 33 10.1046/j.1365-263X.1998.00057.x 9558543
15. Glucose concentration in parotid saliva after glucose/food intake in individuals with glucose intolerance and diabetes mellitus. A Borg Andersson D Birkhed K Berntorp F Lindgarde L Matsson, Eur J Oral Sci 1998 106 5 931 937 10.1046/j.0909-8836.1998.eos106505.x 9786322
16. Laboratory tests in diagnosis and management of diabetes mellitus. Practical considerations. K Miedema, Clin Chem Lab Med 2003 41 9 1259 1265 10.1515/CCLM.2003.193 14598879
17. Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus. MS Yoon V Jankowski S Montag W Zidek L Henning H Schluter M Tepel J Jankowski, Biochem Biophys Res Commun 2004 323 2 377 381 10.1016/j.bbrc.2004.08.118 15369762
18. Relationship of flow rate, uric acid, peroxidase, and superoxide dismutase activity levels with complications in diabetic patients: can saliva be used to diagnose diabetes? M Zloczower AZ Reznick RO Zouby RM Nagler, Antioxid Redox Signal 2007 9 6 765 773 10.1089/ars.2007.1515 17511593
19. Rapid determination of fetal lung maturity from infrared spectra of amniotic fluid. KZ Liu TC Dembinski HH Mantsch, Am J Obstet Gynecol 1998 178 2 234 241 10.1016/S0002-9378(98)80006-9 9500480
20. Spectroscopic diagnosis of myocardial infarction and heart failure by Fourier transform infrared spectroscopy in serum samples. SL Haas R Muller A Fernandes K Dzeyk-Boycheva S Wurl J Hohmann S Hemberger E Elmas M Bruckmann P Bugert, et al. Appl Spectrosc 2010 64 3 262 267 20223059
21. Disease pattern recognition testing for rheumatoid arthritis using infrared spectra of human serum. A Staib B Dolenko DJ Fink J Fruh AE Nikulin M Otto MS Pessin-Minsley O Quarder R Somorjai U Thienel, et al. Clin Chim Acta 2001 308 1-2 79 89 10.1016/S0009-8981(01)00475-2 11412819
22. Infrared spectroscopy: a reagent-free method to distinguish Alzheimer's disease patients from normal-aging subjects. E Peuchant S Richard-Harston I Bourdel-Marchasson JF Dartigues L Letenneur P Barberger-Gateau S Arnaud-Dabernat JY Daniel, Transl Res 2008 152 3 103 112 10.1016/j.trsl.2008.05.009 18774539
23. Application of Fourier-transform infrared (FT-IR) spectroscopy for simple and easy determination of chylomicron-triglyceride and very low density lipoprotein-triglyceride. K Sato M Seimiya Y Kodera A Kitamura F Nomura, Clin Chim Acta 2010 411 3-4 285 290 10.1016/j.cca.2009.11.026 19945450
24. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process. NA Ansari K Alam A Ali, Hum Immunol 2009 70 6 417 424 10.1016/j.humimm.2009.03.015 19332092
25. Determination of glucose and cellobiose dissolved in the ionic liquid 1-ethyl-3-methylimidazolium acetate using Fourier transform infrared spectroscopy. J Kiefer K Obert J Fries A Bosmann P Wasserscheid A Leipertz, Appl Spectrosc 2009 63 9 1041 1049 10.1366/000370209789379367 19796487
26. Infrared spectroscopic identification of beta-thalassemia. KZ Liu KS Tsang CK Li RA Shaw HH Mantsch, Clin Chem 2003 49 7 1125 1132 10.1373/49.7.1125 12816909
27. Tobacco-induced alterations to the Fourier-transform infrared spectrum of serum. JT Borden A Man DA Scott KZ Liu, J Mol Med 2003 81 12 788 794 10.1007/s00109-003-0490-3 14556052
28. Reagent-free, simultaneous determination of serum cholesterol in HDL and LDL by infrared spectroscopy. KZ Liu RA Shaw A Man TC Dembinski HH Mantsch, Clin Chem 2002 48 3 499 506 11861440
29. Thiocyanate levels in human saliva: quantitation by Fourier transform infrared spectroscopy. CP Schultz MK Ahmed C Dawes HH Mantsch, Anal Biochem 1996 240 1 7 12 10.1006/abio.1996.0323 8811872
30. Steady-state kinetics of thiocyanate oxidation catalyzed by human salivary peroxidase. KM Pruitt B Mansson-Rahemtulla DC Baldone F Rahemtulla, Biochemistry 1988 27 1 240 245 10.1021/bi00401a036 3349029
31. Evaluation of two biological markers of tobacco exposure. MRFIT Research Group. KJ Ruth JD Neaton, Prev Med 1991 20 5 574 589 10.1016/0091-7435(91)90056- A 1758839
32. Salivary cholesterol of healthy adults in relation to serum cholesterol concentration and oral health. S Karjalainen L Sewon E Soderling B Larsson I Johansson O Simell H Lapinleimu R Seppanen, J Dent Res 1997 76 10 1637 1643 10.1177/00220345970760100401 9326895
33. Metabolism genes are among the differentially expressed ones observed in lymphomononuclear cells of recently diagnosed type 1 diabetes mellitus patients. DM Rassi CM Junta AL Fachin P Sandrin-Garcia S Mello MM Marques AP Fernandes MC Foss-Freitas MC Foss ET Sakamoto-Hojo, et al. Ann N Y Acad Sci 2006 1079 171 176 10.1196/annals.1375.026 17130550
34. American Diabetes Association. Anonymous, http://www.diabetes.org
35. Point-of-care diagnostics enter the mouth. LA Tabak, Ann N Y Acad Sci 2007 1098 7 14 10.1196/annals.1384.043 17303835
36. Salivary glucose concentration and excretion in normal and diabetic subjects. C Jurysta N Bulur B Oguzhan I Satman TM Yilmaz WJ Malaisse A Sener, Journal of Biomedicine & Biotechnology 2009 2009 430426
37. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. AM Darwazeh TW MacFarlane A McCuish PJ Lamey, Journal of Oral Pathology & Medicine 1991 20 6 280 283
38. Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus. ME Garay-Sevilla JC Regalado JM Malacara LE Nava K Wrobel-Zasada A Castro-Rivas K Wrobel, Journal of Endocrinological Investigation 2005 28 3 223 230 15952406
39. Metabolic regulation by lactate. M Sola-Penna, IUBMB Life 2008 60 9 605 608 10.1002/iub.97 18506840
40. HbA1c as a diagnostic tool for diabetes. B Balkau A Forhan D Simon E Eschwege, International Congress Series 2003 1253 19 26 10.1016/S0531-5131(03) 00540-5
41. Nothing to spit at: the salivary proteome of type 2 diabetes. L Cassiday, J Proteome Res 2009 8 1 3 10.1021/pr8008397 19118447